Paper Review Records
All Paper Review Records
11 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
155
days
A novel DMTN :: HMGA2 rearrangement drives aberrant reactivation of HMGA2 with profibrotic and type I interferon–suppressive signaling
Authors
Yan Lin; Sujuan Zhou; Mei Yang; Nan Chen; Jintao Xu; Xingping Lang; Fan Yang; Sheng Xiao; Lijun Meng; Shouli Wang; Liying ZhangShow moreShow less
Affiliations
1. Department of Hematology, The First People's Hospital of Changzhou; 2. Third Affiliated Hospital of Soochow University; 3. Advanced Molecular Pathology Institute of Soochow University and SANO; 4. Suzhou Sano Precision Medicine Ltd, SANO Medical Laboratories; 5. Department of Pathology; 6. School of Basic Medical Sciences of Soochow University; 7. Department of Hematology; 8. Affiliated Hospital of Nantong University; 9. The Second Affiliated Hospital of Soochow UniversityShow moreShow less
99
days
RecurIndex-derived molecular features associated with total pathological complete response in triple-negative breast cancer: An exploratory prospective cohort study with single-cell transcriptomic contextualization
Authors
Meilin Chen; Xiwen Yan; Qifan Chen; Jiayi Bei; Zheng Pan; Tian Zhang; Weihao Cheng; Lu Xu; Feng Jin; Yan Gao; Zining Jin; Ang ZhengShow moreShow less
Affiliations
1. Beijing Chaoyang Hospital, Capital Medical University, Beijing Chaoyang Hospital; 2. Department of Breast Surgery, The First Hospital of China Medical University; 3. Department of Medical Oncology, The First Hospital of China Medical University; 4. Department of Human Anatomy, School of Basic Medical Sciences, Capital Medical UniversityShow moreShow less
92
days
UBE2S promotes gastric cancer progression through RACGAP1 stabilization associated with K292-dependent K63-linked ubiquitination
Authors
HeFei Cheng; Ziqing Zhou; Qirun Cheng; Ziqi SuiShow moreShow less
Affiliations
1. Department of Gastroenterology, The First People’s Hospital of Linping District; 2. Department of Gastroenterology, The Second Affiliated Hospital of Zhejiang Chinese Medical University; 3. Department of Gastroenterology, Zhejiang HospitalShow moreShow less
111
days
ARHGAP40 suppresses clear cell renal cell carcinoma progression and is associated with altered glutamine-related metabolism and redox balance
Authors
Na You; Xiaoxia Wang; Caizhu Wang; Long Ma; Yanli Lyu; Han Liu; Fan Yang; Jiandong Wang; Longjiang Zhang; Jufang WangShow moreShow less
Affiliations
1. School of Biology and Biological Engineering, South China University of Technology; 2. Guangzhou Huayin Medical Laboratory Center Co, Ltd; 3. Guangzhou Huayin Health Group Co., Ltd; 4. Department of Pathology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University; 5. Department of Radiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University; 6. School of Life Sciences, Jiangsu Key Laboratory for Molecular and Medical Biotechnology, Nanjing Normal UniversityShow moreShow less
178
days
Inhibition of WNT signaling sensitizes CRC cells to anti-tumor effects of retinoids: basis for new drug combinations in oncology
Authors
Victoria O. Hunsu; Caroline O. B. Facey; Lynn M. Opdenaker; Bruce M. BomanShow moreShow less
Affiliations
1. Cawley Center for Translational Cancer Research, Helen F. Graham Cancer Center & Research Institute; 2. Department of Biological Sciences, University of Delaware; 3. Department of Pharmacology & Experimental Therapeutics, Thomas Jefferson UniversityShow moreShow less
108
days
Elevated miR-103b in exosomes derived from brain-metastatic triple-negative breast cancer cells remodels the brain pre-metastatic niche (PMN)
Authors
Li Zhou; Jin Ke; Shanlan Zhang; Sufang Xiao; Hui Zhang; Shan Liu; Li Liu; Mingan Liu; Zuohua Lu; Songguo ZhengShow moreShow less
Affiliations
1. Department of Oncology, Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine; 2. Department of Clinical Laboratory, Pudong Gongli Hospital, Shanghai University of Medicine & Health Sciences; 3. Department of Immunology, The School of Cell & Gene Therapy, Songjiang Research Institute and Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine; 4. State Key Lab of Innovative Immune Therapy, Shanghai Jiao Tong UniversityShow moreShow less
FAQ
How long does CANCER BIOLOGY & THERAPY take to review a manuscript?
As of 2026-11-19, CrushSCI has 11 complete review records for CANCER BIOLOGY & THERAPY. The fastest paper went from submission to acceptance in 53 days (DNA polymerase theta (Polθ): a novel candidate for targeted cancer therapy, received 2026-05-18, accepted 2026-07-10); the slowest took 272 days. The average is 116.2 days and the median is 99 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
